We have located links that may give you full text access.
COMPARATIVE STUDY
JOURNAL ARTICLE
REVIEW
SYSTEMATIC REVIEW
Arterial closure devices versus manual compression for femoral haemostasis in interventional radiological procedures: a systematic review and meta-analysis.
Cardiovascular and Interventional Radiology 2011 August
PURPOSE: The use of arterial closure devices (ACDs) in interventional radiology (IR) procedures has not yet been validated by large-scale randomised controlled trials or meta-analysis. Improved haemostasis and early mobilisation are publicised advantages; however, anecdotal evidence of haemorrhagic and ischaemic complications with ACDs is also apparent. Meta-analysis from interventional cardiology cannot be directly extrapolated for IR patients.
MATERIALS AND METHODS: Systematic review, performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines was performed to assess four ACDs: Angioseal; StarClose; Perclose; and Duettin peripheral vascular interventions: uterine artery embolisation, transhepatic chemoembolisation, and cerebral diagnostic and interventional procedures. Procedures requiring cardiac, aortic, or nonfemoral access, as well as those requiring >8F sheath size, were excluded. The outcomes assessed were device deployment failure, haematoma, bleeding, groin pain, retroperitoneal haematoma, arteriovenous fistula, infection, distal ischaemia, need for vascular surgery, need for manual compression, and death.
RESULTS: Search of MEDLINE and other major databases identified 34 studies from 15,805 records. Twenty-one noncomparative studies (3,662 participants) demonstrated total complication rates of 3.1-11.4%. Thirteen comparative studies were analysed separately, and random-effects meta-analysis yielded 10 studies (2,373 participants).
CONCLUSION: Meta-analyses demonstrated no statistically significant difference, but there were marginally fewer complications with pooled ACDs compared with manual compression (odds ratio [OR] 0.87, 95% confidence interval [CI] 0.52-1.48, p = 0.13). The Angioseal group compared with the manual-compression group (total complication rate: OR 0.84, 95% CI 0.53-1.34, p = 0.49) and the Perclose group compared with the manual-compression group (total complication rate: OR 1.29, 95% CI 0.19-8.96, p = 0.01) each demonstrated trends for and against the specified ACD, respectively. Adequately powered randomised controlled trials are required to further elucidate the efficacy of ACDs.
MATERIALS AND METHODS: Systematic review, performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines was performed to assess four ACDs: Angioseal; StarClose; Perclose; and Duettin peripheral vascular interventions: uterine artery embolisation, transhepatic chemoembolisation, and cerebral diagnostic and interventional procedures. Procedures requiring cardiac, aortic, or nonfemoral access, as well as those requiring >8F sheath size, were excluded. The outcomes assessed were device deployment failure, haematoma, bleeding, groin pain, retroperitoneal haematoma, arteriovenous fistula, infection, distal ischaemia, need for vascular surgery, need for manual compression, and death.
RESULTS: Search of MEDLINE and other major databases identified 34 studies from 15,805 records. Twenty-one noncomparative studies (3,662 participants) demonstrated total complication rates of 3.1-11.4%. Thirteen comparative studies were analysed separately, and random-effects meta-analysis yielded 10 studies (2,373 participants).
CONCLUSION: Meta-analyses demonstrated no statistically significant difference, but there were marginally fewer complications with pooled ACDs compared with manual compression (odds ratio [OR] 0.87, 95% confidence interval [CI] 0.52-1.48, p = 0.13). The Angioseal group compared with the manual-compression group (total complication rate: OR 0.84, 95% CI 0.53-1.34, p = 0.49) and the Perclose group compared with the manual-compression group (total complication rate: OR 1.29, 95% CI 0.19-8.96, p = 0.01) each demonstrated trends for and against the specified ACD, respectively. Adequately powered randomised controlled trials are required to further elucidate the efficacy of ACDs.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app